利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

13 条记录 (耗时 0.023 秒)

    MEDICAL DEVICES INCLUDING HARDENED ALLOYS
    2.
    发明申请
    MEDICAL DEVICES INCLUDING HARDENED ALLOYS 有权
    包括硬化合金的医疗器械

    公开(公告)号：US20080091267A1

    公开(公告)日：2008-04-17

    申请号：US11693498

    申请日：2007-03-29

    申请人： Jonathan S. Stinson ,  Matthew Cambronne ,  Richard B. Frank ,  Richard A. Gleixner ,  James E. Heilmann

    发明人： Jonathan S. Stinson ,  Matthew Cambronne ,  Richard B. Frank ,  Richard A. Gleixner ,  James E. Heilmann

    IPC分类号： C22C38/44 ,  B22F7/04 ,  A61B1/00 ,  B22F7/00 ,  C22C30/00 ,  C22C38/12 ,  C22C38/18 ,  C22C38/40

    CPC分类号： A61L31/022 ,  Y10S623/924

    摘要： Medical devices, such as endoprostheses, and methods of making the devices are disclosed. The endoprostheses comprise a tubular member capable of maintaining patency of a bodily vessel. The tubular member includes a mixture of at least two compositions, where the presence of the second composition gives the mixture a greater hardness than that of the first composition alone. The first composition includes less than about 25 weight percent chromium, less than about 7 weight percent molybdenum, from about 10 to about 35 weight percent nickel, and iron. The second composition is different from the first and is present from about 0.1 weight percent to about 5 weight percent of the mixture.

    摘要翻译： 公开了诸如内置假体的医疗装置和制造装置的方法。 内置假体包括能够维持身体血管通畅的管状构件。 管状构件包括至少两种组合物的混合物，其中第二组合物的存在给予混合物比单独的第一组合物更大的硬度。 第一组合物包括小于约25重量％的铬，小于约7重量％的钼，约10至约35重量％的镍和铁。 第二组合物与第一组合物不同，并且存在约0.1重量％至约5重量％的混合物。

    Molybdenum endoprostheses
    4.
    发明授权
    Molybdenum endoprostheses 有权
    钼内假体

    公开(公告)号：US08398702B2

    公开(公告)日：2013-03-19

    申请号：US11771731

    申请日：2007-06-29

    申请人： Jonathan S. Stinson ,  Matthew Cambronne

    发明人： Jonathan S. Stinson ,  Matthew Cambronne

    IPC分类号： A61F2/06

    CPC分类号： A61F2/82 ,  A61L31/022 ,  A61L31/088 ,  A61L31/10

    摘要： An endoprosthesis can have a member that includes molybdenum and at least one metal selected from the group consisting of titanium, rhenium, yttrium, palladium, rhodium, ruthenium, tungsten, tantalum, iridium, zirconium, hafnium, niobium, chromium, and combinations thereof. The member can have a microstructure characterized by: (a) a molybdenum-rich base region comprising at least 50 weight percent molybdenum, (b) a surface region comprising at least one metal selected from the group consisting of titanium, rhenium, yttrium, palladium, rhodium, ruthenium, tungsten, tantalum, iridium, zirconium, hafnium, niobium, chromium, and combinations thereof, and (c) an inter-diffusion region in which the concentration of molybdenum decreases in the thickness direction from the molybdenum-rich base region to the surface region of the member.

    摘要翻译： 内置假体可以具有包括钼和选自钛，铼，钇，钯，铑，钌，钨，钽，铱，锆，铪，铌，铬及其组合中的至少一种金属的成员。 所述构件可以具有以下特征的微结构：（a）包含至少50重量％的钼的富钼基区，（b）包含选自钛，铼，钇，钯中的至少一种金属的表面区域 ，铑，钌，钨，钽，铱，锆，铪，铌，铬及其组合，以及（c）钼富集基区域的厚度方向上钼浓度的相互扩散区​​域 到构件的表面区域。

    Molybdenum Endoprostheses
    5.
    发明申请
    Molybdenum Endoprostheses 审中-公开

    公开(公告)号：US20130238081A1

    公开(公告)日：2013-09-12

    申请号：US13845865

    申请日：2013-03-18

    申请人： Jonathan S. Stinson ,  Matthew Cambronne

    发明人： Jonathan S. Stinson ,  Matthew Cambronne

    IPC分类号： A61F2/82

    CPC分类号： A61F2/82 ,  A61L31/022 ,  A61L31/088 ,  A61L31/10

    摘要： An endoprosthesis can have a member that includes molybdenum and at least one metal selected from the group consisting of titanium, rhenium, yttrium, palladium, rhodium, ruthenium, tungsten, tantalum, iridium, zirconium, hafnium, niobium, chromium, and combinations thereof. The member can have a microstructure characterized by: (a) a molybdenum-rich base region comprising at least 50 weight percent molybdenum, (b) a surface region comprising at least one metal selected from the group consisting of titanium, rhenium, yttrium, palladium, rhodium, ruthenium, tungsten, tantalum, iridium, zirconium, hafnium, niobium, chromium, and combinations thereof, and (c) an inter-diffusion region in which the concentration of molybdenum decreases in the thickness direction from the molybdenum-rich base region to the surface region of the member.

    Medical devices including hardened alloys
    6.
    发明授权
    Medical devices including hardened alloys 有权
    医疗器械包括硬化合金

    公开(公告)号：US07780798B2

    公开(公告)日：2010-08-24

    申请号：US11693498

    申请日：2007-03-29

    申请人： Jonathan S. Stinson ,  Matthew Cambronne ,  Richard B. Frank ,  Richard A. Gleixner ,  James E. Heilmann

    发明人： Jonathan S. Stinson ,  Matthew Cambronne ,  Richard B. Frank ,  Richard A. Gleixner ,  James E. Heilmann

    IPC分类号： C22C38/40 ,  C22C38/44 ,  C22C5/04 ,  C22C28/00

    CPC分类号： A61L31/022 ,  Y10S623/924

    摘要： Medical devices, such as endoprostheses, and methods of making the devices are disclosed. The endoprostheses comprise a tubular member capable of maintaining patency of a bodily vessel. The tubular member includes a mixture of at least two compositions, where the presence of the second composition gives the mixture a greater hardness than that of the first composition alone. The first composition includes less than about 25 weight percent chromium, less than about 7 weight percent molybdenum, from about 10 to about 35 weight percent nickel, and iron. The second composition is different from the first and is present from about 0.1 weight percent to about 5 weight percent of the mixture.

    摘要翻译： 公开了诸如内置假体的医疗装置和制造装置的方法。 内置假体包括能够维持身体血管通畅的管状构件。 管状构件包括至少两种组合物的混合物，其中第二组合物的存在给予混合物比单独的第一组合物更大的硬度。 第一组合物包括小于约25重量％的铬，小于约7重量％的钼，约10至约35重量％的镍和铁。 第二组合物与第一组合物不同，并且存在约0.1重量％至约5重量％的混合物。

    Molybdenum Endoprostheses
    8.
    发明申请
    Molybdenum Endoprostheses 有权
    钼内假体

    公开(公告)号：US20090005850A1

    公开(公告)日：2009-01-01

    申请号：US11771731

    申请日：2007-06-29

    申请人： Jonathan S. Stinson ,  Matthew Cambronne

    发明人： Jonathan S. Stinson ,  Matthew Cambronne

    IPC分类号： A61F2/06 ,  C22C27/04

    CPC分类号： A61F2/82 ,  A61L31/022 ,  A61L31/088 ,  A61L31/10

    摘要： An endoprosthesis can have a member that includes molybdenum and at least one metal selected from the group consisting of titanium, rhenium, yttrium, palladium, rhodium, ruthenium, tungsten, tantalum, iridium, zirconium, hafnium, niobium, chromium, and combinations thereof. The member can have a microstructure characterized by: (a) a molybdenum-rich base region comprising at least 50 weight percent molybdenum, (b) a surface region comprising at least one metal selected from the group consisting of titanium, rhenium, yttrium, palladium, rhodium, ruthenium, tungsten, tantalum, iridium, zirconium, hafnium, niobium, chromium, and combinations thereof, and (c) an inter-diffusion region in which the concentration of molybdenum decreases in the thickness direction from the molybdenum-rich base region to the surface region of the member.

    摘要翻译： 内置假体可以具有包括钼和选自钛，铼，钇，钯，铑，钌，钨，钽，铱，锆，铪，铌，铬及其组合中的至少一种金属的成员。 所述构件可以具有以下特征的微结构：（a）包含至少50重量％的钼的富钼基区，（b）包含选自钛，铼，钇，钯中的至少一种金属的表面区域 ，铑，钌，钨，钽，铱，锆，铪，铌，铬及其组合，以及（c）钼富集基区域的厚度方向上钼浓度的相互扩散区​​域 到构件的表面区域。

    Medical devices having alloy compositions
    9.
    发明授权
    Medical devices having alloy compositions 有权
    具有合金成分的医疗装置

    公开(公告)号：US09402936B2

    公开(公告)日：2016-08-02

    申请号：US11780060

    申请日：2007-07-19

    申请人： Matthew Cambronne

    发明人： Matthew Cambronne

    IPC分类号： C22C14/00 ,  C22C16/00 ,  A61L31/02 ,  C22F1/18 ,  A61L31/18

    CPC分类号： A61L31/022 ,  A61L31/18 ,  C22C14/00 ,  C22C16/00 ,  C22F1/183 ,  C22F1/186 ,  Y10T428/12639

    摘要： A medical device includes an alloy having a microstructure that provides desirable properties. The alloy can be a eutectoid composition of e.g. titanium as a major constituent and any combination of iridium, platinum, chromium, gold, silver, bismuth, manganese, palladium, cobalt, copper, iron, and/or nickel as a minor constituent, wherein the alloy forms at least a portion of the medical device.

    摘要翻译： 医疗装置包括具有提供所需特性的微结构的合金。 该合金可以是例如共晶体的共析组分。 钛作为主要成分以及作为次要成分的铱，铂，铬，金，银，铋，锰，钯，钴，铜，铁和/或镍的任何组合，其中所述合金形成至少一部分 医疗装置。